12:00 AM
 | 
Apr 03, 2000
 |  BC Week In Review  |  Company News  |  Deals

Cor, CuraGen deal

The companies expanded their 1999 cardiovascular drug discovery agreement to examine additional cell types relevant to vascular...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >